What is the recommended antibiotic for treating histoplasmosis (fungal infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For the treatment of histoplasmosis, itraconazole is the recommended antifungal therapy for mild to moderate disease, while liposomal amphotericin B is recommended for severe or life-threatening infections, followed by step-down therapy to itraconazole. The treatment approach depends on the severity of the disease and the patient's immune status.

Treatment Approach

  • For mild to moderate disease, itraconazole is given at 200 mg three times daily for 3 days as a loading dose, then 200 mg twice daily for at least 12 months 1.
  • For severe or life-threatening infections, liposomal amphotericin B is recommended at 3-5 mg/kg/day intravenously for 1-2 weeks, followed by step-down therapy to itraconazole for a total treatment duration of at least 12 months 1.
  • Fluconazole 800 mg daily can be used as an alternative if itraconazole is not tolerated, though it's less effective 1.

Key Considerations

  • Therapeutic drug monitoring is important for azole therapy to ensure adequate blood levels 1.
  • Treatment duration may be extended in immunocompromised patients, and maintenance therapy might be needed for those with AIDS until immune reconstitution occurs 1.
  • The choice of antifungal therapy should be based on the severity of the disease, the patient's immune status, and the potential for drug interactions and side effects 1.

Monitoring and Adjustments

  • Blood levels of itraconazole should be obtained to ensure adequate drug exposure 1.
  • Antigen levels should be measured during therapy and for 12 months after therapy is ended to monitor for relapse 1.
  • The treatment approach may need to be adjusted based on the patient's response to therapy and the presence of any adverse effects 1.

From the FDA Drug Label

Amphotericin B for Injection USP is specifically intended to treat potentially life-threatening fungal infections: ... histoplasmosis... The recommended antibiotic for treating histoplasmosis is amphotericin B (IV) 2.

  • Key points:
    • Amphotericin B is used for potentially life-threatening fungal infections
    • Histoplasmosis is one of the fungal infections that amphotericin B is intended to treat

From the Research

Treatment Options for Histoplasmosis

The recommended treatment for histoplasmosis depends on the severity of the disease.

  • For moderate to severe and disseminated presentations, amphotericin B is the drug of choice 3, 4, 5, 6.
  • For mild disease, itraconazole is appropriate 3, 4, 5, 6.
  • Itraconazole can also be used as step-down therapy after initial treatment with amphotericin B 3, 6.
  • Posaconazole may be a useful salvage treatment option for histoplasmosis involving a variety of infected tissues and organs 7.

Specific Treatment Recommendations

  • Amphotericin B or one of its lipid formulations is recommended as initial treatment in patients with more extensive diseases, felt to be ill enough to require hospitalization 3.
  • Itraconazole is recommended for those who have milder illness, or to complete treatment after patients respond to amphotericin B 3.
  • Fluconazole therapy for histoplasmosis is only moderately effective 5.

Disease Severity and Treatment

  • The treatment approach varies based on the severity of the disease, with more severe cases requiring hospitalization and initial treatment with amphotericin B 3, 6.
  • Mild cases can be treated with itraconazole 3, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of histoplasmosis.

Seminars in respiratory infections, 2001

Research

Histoplasmosis and blastomycosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996

Research

[Histoplasmosis: not only a tropical disease].

Recenti progressi in medicina, 2000

Research

Salvage treatment of histoplasmosis with posaconazole.

The Journal of infection, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.